Fig. 2From: Safety and efficacy of mavacamten for treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trialsForest plot for Kansas City Cardiomyopathy Questionnaire (KCCQ) scoreBack to article page